Appendix C

Statement of Task

An ad hoc planning committee will plan and conduct a public workshop that will assess the potential economic impact that the advent of genomic medicine may have on clinical practice and research. The workshop will feature presentations and discussions from an array of stakeholders which may include health economists, providers, payers, guideline developers, patients, and regulators. The goal of the workshop will be to advance discussions around the clinical implementation of genetic and genomic technologies by examining costs associated with the development and use of genetic and genomic information in the care of individual patients. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually authored summary of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 99
Appendix C Statement of Task An ad hoc planning committee will plan and conduct a public workshop that will assess the potential economic impact that the advent of genomic medicine may have on clinical practice and research. The workshop will feature presentations and discussions from an array of stakeholders which may include health economists, providers, payers, guideline developers, patients, and regulators. The goal of the workshop will be to advance discussions around the clinical implementation of genetic and genomic technologies by examining costs associated with the development and use of genetic and genomic information in the care of individual patients. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually authored summary of the workshop will be prepared by a designated rap- porteur in accordance with institutional policy and procedures. 99

OCR for page 99